Literature DB >> 8510921

Characterization of the DNA binding and transcriptional activation domains of the erg protein.

H R Siddique1, V N Rao, L Lee, E S Reddy.   

Abstract

erg, an ets related gene encodes a sequence specific DNA binding transcriptional activator protein. We have identified four functional domains of erg protein that are responsible for DNA binding, transcriptional activation and negative regulation of transcriptional activation. Deletion analysis revealed that the 3'-ets domain of the erg protein is sufficient for DNA binding activity. Analysis of these deletion mutants also revealed the presence of two autonomous transcriptional activation domains, one at the amino and the other at the carboxyterminal region. This aminoterminal transcriptional activator domain (5'-ets domain) is conserved in six of the ets genes suggesting that it (ETA, ets Transcriptional Activation domain) may contribute to a common function among these genes. The transcriptional activation function of the carboxy terminal transcriptional activation domain (CTA) was inhibited by the presence of a Negative Regulatory Transcriptional activation domain (NRT), which is located at the amino terminal region of erg DNA binding domain. These results may help in understanding the structure/function relationship of other erg/ets related proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510921

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).

Authors:  H Ichikawa; K Shimizu; R Katsu; M Ohki
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

Authors:  Wendell S Fortson; Shubhalaxmi Kayarthodi; Yasuo Fujimura; Huali Xu; Roland Matthews; William E Grizzle; Veena N Rao; Ganapathy K Bhat; E Shyam P Reddy
Journal:  Int J Oncol       Date:  2011-04-21       Impact factor: 5.650

3.  Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter.

Authors:  Luciano De Haro; Ralf Janknecht
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

4.  Anti-Epileptic Drug Targets Ewing Sarcoma.

Authors:  Shubhalaxmi Kayarthodi; Yasuo Fujimura; Jinbo Fang; Sharif Morsalin; Veena N Rao; E Shyam P Reddy
Journal:  J Pharm Sci Pharmacol       Date:  2014-06-01

5.  The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60.

Authors:  P A Defossez; J L Baert; M Monnot; Y de Launoit
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

6.  Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family.

Authors:  P Oettgen; R M Alani; M A Barcinski; L Brown; Y Akbarali; J Boltax; C Kunsch; K Munger; T A Libermann
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  Autoinhibitory mechanisms of ERG studied by molecular dynamics simulations.

Authors:  Yan Lu; Freddie R Salsbury
Journal:  AIP Adv       Date:  2015-01-22       Impact factor: 1.548

8.  Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells.

Authors:  Jinbo Fang; Huali Xu; Chunshu Yang; Sharif Morsalin; Shubhalaxmi Kayarthodi; Kunchala Rungsrisuriyachai; Ujwala Gunnal; Brittany Mckenzie; Veena N Rao; E Shyam P Reddy
Journal:  J Pharm Sci Pharmacol       Date:  2014-09-01

Review 9.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions.

Authors:  Rajareddy Singareddy; Louie Semaan; M Katie Conley-Lacomb; Jason St John; Katelyn Powell; Matthew Iyer; Daryn Smith; Lance K Heilbrun; Dongping Shi; Wael Sakr; Michael L Cher; Sreenivasa R Chinni
Journal:  Mol Cancer Res       Date:  2013-08-05       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.